رجوع
نطاق اليوم
KWD 9.90
KWD 10.36
نطاق 52 أسبوعًا
KWD 2.60
KWD 11.23
حجم التداول
172,106
متوسط 50 يوم / 200 يوم
KWD 10.15
/
KWD 7.17
الإغلاق السابق
KWD 10.17
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -9.1 | 0.3 |
| P/B | 3.0 | 2.9 |
| ROE % | -30.7 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 15.670
+52.0%
Low: KWD 14.000
High: KWD 18.000
ربحية السهم المستقبلية
-KWD 1.363
الإيرادات المقدّرة
120 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
-KWD 0.410
-KWD 0.410 – -KWD 0.410
|
220 M | 2 |
| FY2029 |
-KWD 1.614
-KWD 1.614 – -KWD 1.614
|
69 M | 2 |
| FY2028 |
-KWD 2.010
-KWD 2.375 – -KWD 1.608
|
8.5 M | 4 |
النقاط الرئيسية
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -54.55M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-30.70%
ROIC-27.96%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.00
Current Ratio17.14
Interest Coverage0.00
التقييم
P/E Ratio
-9.11
P/B Ratio2.99
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -69.79M |
| ROE | -30.70% | ROA | -30.85% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -54.55M |
| ROIC | -27.96% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 17.14 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.11 | P/B Ratio | 2.99 |
| P/S Ratio | N/A | PEG Ratio | -0.20 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 635.84M | Enterprise Value | 619.63M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -69.79M | -49.59M | -66.86M | -63.31M | -35.53M |
| EPS (Diluted) | -1.22 | -0.88 | -1.19 | -1.14 | -0.77 |
| Gross Profit | -622,000.0 | -596,000.0 | -537,000.0 | -466,000.0 | 0.0 |
| Operating Income | -79.47M | -62.38M | -78.19M | -67.59M | -35.83M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 226.20M | 252.09M | 289.64M | 341.14M | 390.56M |
| Total Liabilities | 13.70M | 10.00M | 11.96M | 13.83M | 8.43M |
| Shareholders' Equity | 212.50M | 242.10M | 277.69M | 327.31M | 382.13M |
| Total Debt | 645,000.0 | 2.33M | 3.05M | 3.69M | 3.63M |
| Cash & Equivalents | 16.86M | 22.56M | 21.20M | 26.50M | 298.57M |
| Current Assets | 223.78M | 248.04M | 284.58M | 335.12M | 385.44M |
| Current Liabilities | 13.06M | 8.46M | 9.62M | 10.78M | 5.28M |